K, Y., A, I., & H, M. (2026). Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development. Clinical and translational science, 19(6), e70635. https://doi.org/10.1111/cts.70635
Chicago Style (17th ed.) CitationK, Yamamoto, Iwase A, and Maeda H. "Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development." Clinical and Translational Science 19, no. 6 (2026): e70635. https://doi.org/10.1111/cts.70635.
MLA (9th ed.) CitationK, Yamamoto, et al. "Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development." Clinical and Translational Science, vol. 19, no. 6, 2026, p. e70635, https://doi.org/10.1111/cts.70635.